1-10 of 10
Hiroyoshi Nishikawa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correlation between Changes in Granzyme B Expression and Time to Progression in Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide and Dexamethasone Therapy

Takahiro Kobayashi, MD PhD, Yuki Fujioka, MD PhD, Sho Ikeda, MD PhD, Hiroyoshi Nishikawa, MD PhD, Naoto Takahashi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1792.
https://doi.org/10.1182/blood-2019-125649
Published: 2019
Journal Articles

Optimum Imatinib Exposure Have Possibility of Leading to Appropriate Immune Response after Imatinib Discontinuation in CML Patients

Yuki Fujioka, MD PhD, Hiroyoshi Nishikawa, MD PhD, Naoto Takahashi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 192.
https://doi.org/10.1182/blood-2019-130300
Published: 2019
Journal Articles

Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide

Takahiro Kobayashi, MD, Masatomo Miura, Takenori Niioka, Yuki Fujioka, Maiko Abumiya, Tomoko Yoshioka, Yoshihiro Kameoka, Hiroyoshi Nishikawa, Naoto Takahashi
Journal: Blood
Blood (2017) 130 (Supplement 1): 3846.
https://doi.org/10.1182/blood.V130.Suppl_1.3846.3846
Published: 2017
Journal Articles

Kinetics of Regulatory T Cells Predict the Recurrence of CML after Stopping Imatinib in Japanese CML Patiens

Yuki Fujioka, MD, Hiroyoshi Nishikawa, MD PhD, Naoto Takahashi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4240.
https://doi.org/10.1182/blood.V128.22.4240.4240
Published: 2016
Journal Articles

Clinical Impact of Pre-Transplant Microbial Diversity on Transplant Outcomes

Shuhei Kurosawa, Noriko Doki, Masahiro Suyama, Satoshi Sasajima, Aiko Igarashi, Iyo Mimura, Hidetoshi Morita, Yuki Fujioka, MD, Hiroyoshi Nishikawa, MD PhD, Yutaka Shimazu, Wataru Suda, Masahira Hattori, Yuho Najima, Kazuhiko Kakihana, Hisashi Sakamaki, Kenya Honda, Kazuteru Ohashi
Journal: Blood
Blood (2016) 128 (22): 4577.
https://doi.org/10.1182/blood.V128.22.4577.4577
Published: 2016
Journal Articles

Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

CME Clinical Trials & Observations Brief Report
Kazuhiko Kakihana, Yuki Fujioka, Wataru Suda, Yuho Najima, Go Kuwata, Satoshi Sasajima, Iyo Mimura, Hidetoshi Morita, Daisuke Sugiyama, Hiroyoshi Nishikawa, Masahira Hattori, Yutaro Hino, Shuntaro Ikegawa, Keita Yamamoto, Takashi Toya, Noriko Doki, Koichi Koizumi, Kenya Honda, Kazuteru Ohashi
Journal: Blood
Blood (2016) 128 (16): 2083–2088.
https://doi.org/10.1182/blood-2016-05-717652
Published: 2016
Includes: Supplemental data
Journal Articles

Tyrosine Kinase Inhibitor Imatinib Enhances Tumor Immunity By Depleting Functionally Mature Regulatory T Cells

Shinsuke Noguchi, MD, Hiroyoshi Nishikawa, MD, PhD, Hirobumi Saitoh, MD, PhD, Atsushi Ohshima, MD, PhD, Kenichi Sawada, MD, PhD, Shimon Sakaguchi, MD PhD, Naoto Takahashi, MD PhD FJSIM
Journal: Blood
Blood (2015) 126 (23): 2219.
https://doi.org/10.1182/blood.V126.23.2219.2219
Published: 2015
Journal Articles

Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma

Hiroyoshi Nishikawa, Yuka Maeda, Takashi Ishida, Sacha Gnjatic, Eiichi Sato, Fumiko Mori, Daisuke Sugiyama, Asahi Ito, Yasuo Fukumori, Atae Utsunomiya, Hiroshi Inagaki, Lloyd J. Old, Ryuzo Ueda, Shimon Sakaguchi
Journal: Blood
Blood (2012) 119 (13): 3097–3104.
https://doi.org/10.1182/blood-2011-09-379982
Published: 2012
Includes: Supplemental data
Journal Articles

Induction of regulatory T cell–resistant helper CD4 + T cells by bacterial vector

Hiroyoshi Nishikawa, Takemasa Tsuji, Elke Jäger, Gabriel Briones, Gerd Ritter, Lloyd J. Old, Jorge E. Galán, Hiroshi Shiku, Sacha Gnjatic
Journal: Blood
Blood (2008) 111 (3): 1404–1412.
https://doi.org/10.1182/blood-2007-09-113761
Published: 2008
Includes: Supplemental data
Journal Articles

CD4 + CD25 + regulatory T cells control the induction of antigen-specific CD4 + helper T cell responses in cancer patients

Clinical Trials & Observations Brief Report
Hiroyoshi Nishikawa, Elke Jäger, Gerd Ritter, Lloyd J. Old, Sacha Gnjatic
Journal: Blood
Blood (2005) 106 (3): 1008–1011.
https://doi.org/10.1182/blood-2005-02-0607
Published: 2005
Includes: Supplemental data